Pular para o conteúdo
Dr. Lucas Menezes

Bibliografia

Toda afirmação clínica do método tem citação numerada dentro da própria trilha. Aqui estão as listas completas, por trilha, com DOI.

trilha I

Transtornos de Humor

  1. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905-17. doi:10.1176/ajp.2006.163.11.1905coorte
  2. Lam RW, Kennedy SH, Adams C, Bahji A, Beaulieu S, Bhat V, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 update on clinical guidelines for management of major depressive disorder in adults. Can J Psychiatry. 2024;69(9):641-87. doi:10.1177/07067437241245384diretriz
  3. Hage MP, Azar ST. The link between thyroid function and depression. J Thyroid Res. 2012;2012:590648. doi:10.1155/2012/590648revisao
  4. Coppen A, Bolander-Gouaille C. Treatment of depression: time to consider folic acid and vitamin B12. J Psychopharmacol. 2005;19(1):59-65. doi:10.1177/0269881105048899revisao
  5. Anglin RE, Samaan Z, Walter SD, McDonald SD. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry. 2013;202:100-7. doi:10.1192/bjp.bp.111.106666meta-analise
  6. Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the National Depressive and Manic-Depressive Association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry. 2003;64(2):161-74. doi:10.4088/JCP.v64n0209outro
  7. Firth J, Solmi M, Wootton RE, Vancampfort D, Schuch FB, Hoare E, et al. A meta-review of "lifestyle psychiatry": the role of exercise, smoking, diet and sleep in the prevention and treatment of mental disorders. World Psychiatry. 2020;19(3):360-80. doi:10.1002/wps.20773revisao
  8. Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97-170. doi:10.1111/bdi.12609diretriz
  9. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-13. doi:10.1046/j.1525-1497.2001.016009606.xinstrumento
  10. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-7. doi:10.1001/archinte.166.10.1092instrumento
  11. Hirschfeld RM, Williams JB, Spitzer RL, Calabrese JR, Flynn L, Keck PE Jr, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000;157(11):1873-5. doi:10.1176/appi.ajp.157.11.1873instrumento
  12. Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001;2(4):297-307. doi:10.1016/S1389-9457(00)00065-4instrumento
  13. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Arch Intern Med. 1998;158(16):1789-95. doi:10.1001/archinte.158.16.1789instrumento
  14. Vaucher P, Druais PL, Waldvogel S, Favrat B. Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial. CMAJ. 2012;184(11):1247-54. doi:10.1503/cmaj.110950ensaio
  15. Pan A, Keum N, Okereke OI, Sun Q, Kivimaki M, Rubin RR, et al. Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care. 2012;35(5):1171-80. doi:10.2337/dc11-2055meta-analise
  16. Osimo EF, Baxter LJ, Lewis G, Jones PB, Khandaker GM. Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels. Psychol Med. 2019;49(12):1958-70. doi:10.1017/S0033291719001454meta-analise
  17. Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 2011;135(1-3):10-9. doi:10.1016/j.jad.2011.01.011meta-analise
  18. Peppard PE, Szklo-Coxe M, Hla KM, Young T. Longitudinal association of sleep-related breathing disorder and depression. Arch Intern Med. 2006;166(16):1709-15. doi:10.1001/archinte.166.16.1709coorte
  19. Dazzi T, Gribble R, Wessely S, Fear NT. Does asking about suicide and related behaviours induce suicidal ideation? What is the evidence? Psychol Med. 2014;44(16):3361-3. doi:10.1017/S0033291714001299revisao
  20. National Institute for Health and Care Excellence. Depression in adults: treatment and management. NICE guideline NG222. London: NICE; 2022. linkdiretriz
  21. Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments. Can J Psychiatry. 2016;61(9):540-60. doi:10.1177/0706743716659417diretriz
  22. Parikh SV, Quilty LC, Ravitz P, Rosenbluth M, Pavlova B, Grigoriadis S, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 2. Psychological treatments. Can J Psychiatry. 2016;61(9):524-39. doi:10.1177/0706743716659418diretriz
  23. Ravindran AV, Balneaves LG, Faulkner G, Ortiz A, McIntosh D, Morehouse RL, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 5. Complementary and alternative medicine treatments. Can J Psychiatry. 2016;61(9):576-87. doi:10.1177/0706743716660290diretriz
  24. Bauer M, Severus E, Köhler S, Whybrow PC, Angst J, Möller HJ; WFSBP Task Force on Treatment Guidelines for Unipolar Depressive Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. Part 2: maintenance treatment of major depressive disorder, update 2015. World J Biol Psychiatry. 2015;16(2):76-95. doi:10.3109/15622975.2014.1001786diretriz
  25. Cooney GM, Dwan K, Greig CA, Lawlor DA, Rimer J, Waugh FR, et al. Exercise for depression. Cochrane Database Syst Rev. 2013;(9):CD004366. doi:10.1002/14651858.CD004366.pub6meta-analise
  26. Noetel M, Sanders T, Gallardo-Gómez D, Taylor P, del Pozo Cruz B, van den Hoek D, et al. Effect of exercise for depression: systematic review and network meta-analysis of randomised controlled trials. BMJ. 2024;384:e075847. doi:10.1136/bmj-2023-075847meta-analise
  27. Firth J, Marx W, Dash S, Carney R, Teasdale SB, Solmi M, et al. The effects of dietary improvement on symptoms of depression and anxiety: a meta-analysis of randomized controlled trials. Psychosom Med. 2019;81(3):265-80. doi:10.1097/PSY.0000000000000673meta-analise
  28. Liao Y, Xie B, Zhang H, He Q, Guo L, Subramanieapillai M, et al. Efficacy of omega-3 PUFAs in depression: a meta-analysis. Transl Psychiatry. 2019;9(1):190. doi:10.1038/s41398-019-0515-5meta-analise
  29. Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet. 2003;361(9358):653-61. doi:10.1016/S0140-6736(03)12599-8meta-analise
  30. Gelenberg AJ, Freeman MP, Markowitz JC, Rosenbaum JF, Thase ME, Trivedi MH, et al. Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. Arlington (VA): American Psychiatric Association; 2010. doi:10.1176/appi.books.9780890423387.654001diretriz

trilha II

TDAH

  1. Faraone SV, Banaschewski T, Coghill D, Zheng Y, Biederman J, Bellgrove MA, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neurosci Biobehav Rev. 2021;128:789-818. doi:10.1016/j.neubiorev.2021.01.022consenso
  2. National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: diagnosis and management. NICE guideline NG87. London: NICE; 2018 (atualizada em 2019). linkdiretriz
  3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022. doi:10.1176/appi.books.9780890425787livro
  4. Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi E, et al. The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245-56. doi:10.1017/S0033291704002892instrumento
  5. Ustun B, Adler LA, Rudin C, Faraone SV, Spencer TJ, Berglund P, et al. The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5. JAMA Psychiatry. 2017;74(5):520-6. doi:10.1001/jamapsychiatry.2017.0298instrumento
  6. Kooij JJS, Bijlenga D, Salerno L, Jaeschke R, Bitter I, Balázs J, et al. Updated European Consensus Statement on diagnosis and treatment of adult ADHD. Eur Psychiatry. 2019;56:14-34. doi:10.1016/j.eurpsy.2018.11.001consenso
  7. Kooij JJS, Francken MH, Bron TI, Wynchank D. Diagnostic Interview for ADHD in adults (DIVA-5). The Hague: DIVA Foundation; 2019. linkinstrumento
  8. Weiss MD, McBride NM, Craig S, Jensen P. Conceptual review of measuring functional impairment: findings from the Weiss Functional Impairment Rating Scale. Evid Based Ment Health. 2018;21(4):155-64. doi:10.1136/ebmental-2018-300025instrumento
  9. Üstün TB, Chatterji S, Kostanjsek N, Rehm J, Kennedy C, Epping-Jordan J, et al. Developing the World Health Organization Disability Assessment Schedule 2.0. Bull World Health Organ. 2010;88(11):815-23. doi:10.2471/BLT.09.067231instrumento
  10. Caye A, Rocha TB, Anselmi L, Murray J, Menezes AMB, Barros FC, et al. Attention-deficit/hyperactivity disorder trajectories from childhood to young adulthood: evidence from a birth cohort supporting a late-onset syndrome. JAMA Psychiatry. 2016;73(7):705-12. doi:10.1001/jamapsychiatry.2016.0383coorte
  11. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163(4):716-23. doi:10.1176/ajp.2006.163.4.716coorte
  12. Schiweck C, Arteaga-Henriquez G, Aichholzer M, Edwin Thanarajah S, Vargas-Cáceres S, Matura S, et al. Comorbidity of ADHD and adult bipolar disorder: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2021;124:100-23. doi:10.1016/j.neubiorev.2021.01.017meta-analise
  13. Lee SS, Humphreys KL, Flory K, Liu R, Glass K. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev. 2011;31(3):328-41. doi:10.1016/j.cpr.2011.01.006meta-analise
  14. Hvolby A. Associations of sleep disturbance with ADHD: implications for treatment. Atten Defic Hyperact Disord. 2015;7(1):1-18. doi:10.1007/s12402-014-0151-0revisao
  15. Wynchank D, Bijlenga D, Beekman AT, Kooij JJS, Penninx BW. Adult attention-deficit/hyperactivity disorder (ADHD) and insomnia: an update of the literature. Curr Psychiatry Rep. 2017;19(12):98. doi:10.1007/s11920-017-0860-0revisao
  16. Bijlenga D, Vollebregt MA, Kooij JJS, Arns M. The role of the circadian system in the etiology and pathophysiology of ADHD: time to redefine ADHD? Atten Defic Hyperact Disord. 2019;11(1):5-19. doi:10.1007/s12402-018-0271-zrevisao
  17. Wang Y, Huang L, Zhang L, Qu Y, Mu D. Iron status in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. PLoS One. 2017;12(1):e0169145. doi:10.1371/journal.pone.0169145meta-analise
  18. Cortese S, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727-38. doi:10.1016/S2215-0366(18)30269-4meta-analise
  19. Chang Z, Quinn PD, Hur K, Gibbons RD, Sjölander A, Larsson H, et al. Association between medication use for attention-deficit/hyperactivity disorder and risk of motor vehicle crashes. JAMA Psychiatry. 2017;74(6):597-603. doi:10.1001/jamapsychiatry.2017.0659coorte
  20. Chang Z, Ghirardi L, Quinn PD, Asherson P, D'Onofrio BM, Larsson H. Risks and benefits of attention-deficit/hyperactivity disorder medication on behavioral and neuropsychiatric outcomes: a qualitative review of pharmacoepidemiology studies using linked prescription databases. Biol Psychiatry. 2019;86(5):335-43. doi:10.1016/j.biopsych.2019.04.009revisao
  21. Zhang L, Li L, Andell P, Garcia-Argibay M, Quinn PD, D'Onofrio BM, et al. Attention-deficit/hyperactivity disorder medications and long-term risk of cardiovascular diseases. JAMA Psychiatry. 2024;81(2):178-87. doi:10.1001/jamapsychiatry.2023.4294coorte
  22. Cerrillo-Urbina AJ, García-Hermoso A, Sánchez-López M, Pardo-Guijarro MJ, Santos Gómez JL, Martínez-Vizcaíno V. The effects of physical exercise in children with attention deficit hyperactivity disorder: a systematic review and meta-analysis of randomized control trials. Child Care Health Dev. 2015;41(6):779-88. doi:10.1111/cch.12255meta-analise
  23. Solanto MV, Marks DJ, Wasserstein J, Mitchell K, Abikoff H, Alvir JM, et al. Efficacy of meta-cognitive therapy for adult ADHD. Am J Psychiatry. 2010;167(8):958-68. doi:10.1176/appi.ajp.2009.09081123ensaio
  24. Safren SA, Sprich S, Mimiaga MJ, Surman C, Knouse L, Groves M, et al. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. JAMA. 2010;304(8):875-80. doi:10.1001/jama.2010.1192ensaio
  25. Knouse LE, Teller J, Brooks MA. Meta-analysis of cognitive-behavioral treatments for adult ADHD. J Consult Clin Psychol. 2017;85(7):737-50. doi:10.1037/ccp0000216meta-analise
  26. Ra CK, Cho J, Stone MD, De La Cerda J, Goldenson NI, Moroney E, et al. Association of digital media use with subsequent symptoms of attention-deficit/hyperactivity disorder among adolescents. JAMA. 2018;320(3):255-63. doi:10.1001/jama.2018.8931coorte
  27. Pelsser LM, Frankena K, Toorman J, Rodrigues Pereira R. Diet and ADHD, reviewing the evidence: a systematic review of meta-analyses of double-blind placebo-controlled trials evaluating the efficacy of diet interventions on the behavior of children with ADHD. PLoS One. 2017;12(1):e0169277. doi:10.1371/journal.pone.0169277revisao
  28. Shaw P, Stringaris A, Nigg J, Leibenluft E. Emotion dysregulation in attention deficit hyperactivity disorder. Am J Psychiatry. 2014;171(3):276-93. doi:10.1176/appi.ajp.2013.13070966revisao
  29. Dalsgaard S, Østergaard SD, Leckman JF, Mortensen PB, Pedersen MG. Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study. Lancet. 2015;385(9983):2190-6. doi:10.1016/S0140-6736(14)61684-6coorte
  30. Sibley MH, Arnold LE, Swanson JM, Hechtman LT, Kennedy TM, Owens E, et al. Variable patterns of remission from ADHD in the Multimodal Treatment Study of ADHD. Am J Psychiatry. 2022;179(2):142-51. doi:10.1176/appi.ajp.2021.21010032coorte

trilha III

Transtorno do Espectro Autista

  1. Lord C, Elsabbagh M, Baird G, Veenstra-Vanderweele J. Autism spectrum disorder. Lancet. 2018;392(10146):508-520. doi:10.1016/S0140-6736(18)31129-2revisao
  2. Lord C, Charman T, Havdahl A, Carbone P, Anagnostou E, Boyd B, et al. The Lancet Commission on the future of care and clinical research in autism. Lancet. 2022;399(10321):271-334. doi:10.1016/S0140-6736(21)01541-5consenso
  3. National Institute for Health and Care Excellence. Autism spectrum disorder in adults: diagnosis and management. Clinical guideline CG142. London: NICE; 2012 (atualizada em 2021). linkdiretriz
  4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022. doi:10.1176/appi.books.9780890425787livro
  5. Loomes R, Hull L, Mandy WPL. What is the male-to-female ratio in autism spectrum disorder? A systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2017;56(6):466-474. doi:10.1016/j.jaac.2017.03.013meta-analise
  6. Baron-Cohen S, Wheelwright S, Skinner R, Martin J, Clubley E. The Autism-Spectrum Quotient (AQ): evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord. 2001;31(1):5-17. doi:10.1023/A:1005653411471instrumento
  7. Allison C, Auyeung B, Baron-Cohen S. Toward brief "red flags" for autism screening: the Short Autism Spectrum Quotient and the Short Quantitative Checklist in 1,000 cases and 3,000 controls. J Am Acad Child Adolesc Psychiatry. 2012;51(2):202-212.e7. doi:10.1016/j.jaac.2011.11.003instrumento
  8. Ritvo RA, Ritvo ER, Guthrie D, Ritvo MJ, Hufnagel DH, McMahon W, et al. The Ritvo Autism Asperger Diagnostic Scale-Revised (RAADS-R): a scale to assist the diagnosis of autism spectrum disorder in adults: an international validation study. J Autism Dev Disord. 2011;41(8):1076-1089. doi:10.1007/s10803-010-1133-5instrumento
  9. Hull L, Mandy W, Lai MC, Baron-Cohen S, Allison C, Smith P, et al. Development and validation of the Camouflaging Autistic Traits Questionnaire (CAT-Q). J Autism Dev Disord. 2019;49(3):819-833. doi:10.1007/s10803-018-3792-6instrumento
  10. Hull L, Petrides KV, Allison C, Smith P, Baron-Cohen S, Lai MC, et al. "Putting on my best normal": social camouflaging in adults with autism spectrum conditions. J Autism Dev Disord. 2017;47(8):2519-2534. doi:10.1007/s10803-017-3166-5outro
  11. Lai MC, Baron-Cohen S. Identifying the lost generation of adults with autism spectrum conditions. Lancet Psychiatry. 2015;2(11):1013-1027. doi:10.1016/S2215-0366(15)00277-1revisao
  12. Lord C, Rutter M, Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord. 1994;24(5):659-685. doi:10.1007/BF02172145instrumento
  13. Lai MC, Kassee C, Besney R, Bonato S, Hull L, Mandy W, et al. Prevalence of co-occurring mental health diagnoses in the autism population: a systematic review and meta-analysis. Lancet Psychiatry. 2019;6(10):819-829. doi:10.1016/S2215-0366(19)30289-5meta-analise
  14. Hollocks MJ, Lerh JW, Magiati I, Meiser-Stedman R, Brugha TS. Anxiety and depression in adults with autism spectrum disorder: a systematic review and meta-analysis. Psychol Med. 2019;49(4):559-572. doi:10.1017/S0033291718002283meta-analise
  15. Raymaker DM, Teo AR, Steckler NA, Lentz B, Scharer M, Delos Santos A, et al. "Having all of your internal resources exhausted beyond measure and being left with no clean-up crew": defining autistic burnout. Autism Adulthood. 2020;2(2):132-143. doi:10.1089/aut.2019.0079outro
  16. Cassidy S, Bradley P, Robinson J, Allison C, McHugh M, Baron-Cohen S. Suicidal ideation and suicide plans or attempts in adults with Asperger's syndrome attending a specialist diagnostic clinic: a clinical cohort study. Lancet Psychiatry. 2014;1(2):142-147. doi:10.1016/S2215-0366(14)70248-2coorte
  17. Hirvikoski T, Mittendorfer-Rutz E, Boman M, Larsson H, Lichtenstein P, Bölte S. Premature mortality in autism spectrum disorder. Br J Psychiatry. 2016;208(3):232-238. doi:10.1192/bjp.bp.114.160192coorte
  18. Lukmanji S, Manji SA, Kadhim S, Sauro KM, Wirrell EC, Kwon CS, et al. The co-occurrence of epilepsy and autism: a systematic review. Epilepsy Behav. 2019;98(Pt A):238-248. doi:10.1016/j.yebeh.2019.07.037revisao
  19. Chaidez V, Hansen RL, Hertz-Picciotto I. Gastrointestinal problems in children with autism, developmental delays or typical development. J Autism Dev Disord. 2014;44(5):1117-1127. doi:10.1007/s10803-013-1973-xcoorte
  20. Sharp WG, Berry RC, McCracken C, Nuhu NN, Marvel E, Saulnier CA, et al. Feeding problems and nutrient intake in children with autism spectrum disorders: a meta-analysis and comprehensive review of the literature. J Autism Dev Disord. 2013;43(9):2159-2173. doi:10.1007/s10803-013-1771-5meta-analise
  21. Ben-Sasson A, Hen L, Fluss R, Cermak SA, Engel-Yeger B, Gal E. A meta-analysis of sensory modulation symptoms in individuals with autism spectrum disorders. J Autism Dev Disord. 2009;39(1):1-11. doi:10.1007/s10803-008-0593-3meta-analise
  22. Salanitro M, Wrigley T, Ghabra H, de Haan E, Hill CM, Solmi M, et al. Efficacy on sleep parameters and tolerability of melatonin in individuals with sleep or mental disorders: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2022;139:104723. doi:10.1016/j.neubiorev.2022.104723meta-analise
  23. Gringras P, Nir T, Breddy J, Frydman-Marom A, Findling RL. Efficacy and safety of pediatric prolonged-release melatonin for insomnia in children with autism spectrum disorder. J Am Acad Child Adolesc Psychiatry. 2017;56(11):948-957.e4. doi:10.1016/j.jaac.2017.09.414ensaio
  24. Weston L, Hodgekins J, Langdon PE. Effectiveness of cognitive behavioural therapy with people who have autistic spectrum disorders: a systematic review and meta-analysis. Clin Psychol Rev. 2016;49:41-54. doi:10.1016/j.cpr.2016.08.001meta-analise
  25. Gates JA, Kang E, Lerner MD. Efficacy of group social skills interventions for youth with autism spectrum disorder: a systematic review and meta-analysis. Clin Psychol Rev. 2017;52:164-181. doi:10.1016/j.cpr.2017.01.006meta-analise
  26. Persico AM, Ricciardello A, Lamberti M, Turriziani L, Cucinotta F, Brogna C, et al. The pediatric psychopharmacology of autism spectrum disorder: a systematic review. Part I: the past and the present. Prog Neuropsychopharmacol Biol Psychiatry. 2021;110:110326. doi:10.1016/j.pnpbp.2021.110326revisao
  27. Schaaf RC, Benevides T, Mailloux Z, Faller P, Hunt J, van Hooydonk E, et al. An intervention for sensory difficulties in children with autism: a randomized trial. J Autism Dev Disord. 2014;44(7):1493-1506. doi:10.1007/s10803-013-1983-8ensaio
  28. Taylor LE, Swerdfeger AL, Eslick GD. Vaccines are not associated with autism: an evidence-based meta-analysis of case-control and cohort studies. Vaccine. 2014;32(29):3623-3629. doi:10.1016/j.vaccine.2014.04.085meta-analise
  29. Brasil. Lei n. 12.764, de 27 de dezembro de 2012. Institui a Política Nacional de Proteção dos Direitos da Pessoa com Transtorno do Espectro Autista. Diário Oficial da União; 2012. linkoutro
  30. Brasil. Lei n. 13.977, de 8 de janeiro de 2020 (Lei Romeo Mion). Cria a Carteira de Identificação da Pessoa com Transtorno do Espectro Autista (CIPTEA). Diário Oficial da União; 2020. linkoutro

trilha IV

Transtornos de Personalidade

  1. Gunderson JG, Herpertz SC, Skodol AE, Torgersen S, Zanarini MC. Borderline personality disorder. Nat Rev Dis Primers. 2018;4:18029. doi:10.1038/nrdp.2018.29revisao
  2. Bohus M, Stoffers-Winterling J, Sharp C, Krause-Utz A, Schmahl C, Lieb K. Borderline personality disorder. Lancet. 2021;398(10310):1528-1540. doi:10.1016/S0140-6736(21)00476-1revisao
  3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022. doi:10.1176/appi.books.9780890425787livro
  4. Bach B, First MB. Application of the ICD-11 classification of personality disorders. BMC Psychiatry. 2018;18(1):351. doi:10.1186/s12888-018-1908-3revisao
  5. Krueger RF, Derringer J, Markon KE, Watson D, Skodol AE. Initial construction of a maladaptive personality trait model and inventory for DSM-5. Psychol Med. 2012;42(9):1879-1890. doi:10.1017/S0033291711002674instrumento
  6. Maples JL, Carter NT, Few LR, Crego C, Gore WL, Samuel DB, et al. Testing whether the DSM-5 personality disorder trait model can be measured with a reduced set of items: an item response theory investigation of the Personality Inventory for DSM-5. Psychol Assess. 2015;27(4):1195-1210. doi:10.1037/pas0000120instrumento
  7. Moran P, Leese M, Lee T, Walters P, Thornicroft G, Mann A. Standardised Assessment of Personality - Abbreviated Scale (SAPAS): preliminary validation of a brief screen for personality disorder. Br J Psychiatry. 2003;183:228-232. doi:10.1192/bjp.183.3.228instrumento
  8. Zanarini MC, Vujanovic AA, Parachini EA, Boulanger JL, Frankenburg FR, Hennen J. A screening measure for BPD: the McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD). J Pers Disord. 2003;17(6):568-573. doi:10.1521/pedi.17.6.568.25355instrumento
  9. Gratz KL, Roemer L. Multidimensional assessment of emotion regulation and dysregulation: development, factor structure, and initial validation of the Difficulties in Emotion Regulation Scale. J Psychopathol Behav Assess. 2004;26(1):41-54. doi:10.1023/B:JOBA.0000007455.08539.94instrumento
  10. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613. doi:10.1046/j.1525-1497.2001.016009606.xinstrumento
  11. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-1097. doi:10.1001/archinte.166.10.1092instrumento
  12. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction. 1993;88(6):791-804. doi:10.1111/j.1360-0443.1993.tb02093.xinstrumento
  13. Zimmerman M, Morgan TA. The relationship between borderline personality disorder and bipolar disorder. Dialogues Clin Neurosci. 2013;15(2):155-169. doi:10.31887/DCNS.2013.15.2/mzimmermanrevisao
  14. Ditrich I, Philipsen A, Matthies S. Borderline personality disorder (BPD) and attention deficit hyperactivity disorder (ADHD) revisited - a review-update on common grounds and subtle distinctions. Borderline Personal Disord Emot Dysregul. 2021;8(1):22. doi:10.1186/s40479-021-00162-wrevisao
  15. Ford JD, Courtois CA. Complex PTSD and borderline personality disorder. Borderline Personal Disord Emot Dysregul. 2021;8(1):16. doi:10.1186/s40479-021-00155-9revisao
  16. Winsper C, Tang NKY, Marwaha S, Lereya ST, Gibbs M, Thompson A, et al. The sleep phenotype of borderline personality disorder: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2017;73:48-67. doi:10.1016/j.neubiorev.2016.12.008meta-analise
  17. Firth J, Solmi M, Wootton RE, Vancampfort D, Schuch FB, Hoare E, et al. A meta-review of "lifestyle psychiatry": the role of exercise, smoking, diet and sleep in the treatment of mental disorders. World Psychiatry. 2020;19(3):360-380. doi:10.1002/wps.20773meta-analise
  18. National Institute for Health and Care Excellence. Borderline personality disorder: recognition and management. Clinical guideline CG78. London: NICE; 2009. linkdiretriz
  19. Storebø OJ, Stoffers-Winterling JM, Völlm BA, Kongerslev MT, Mattivi JT, Jørgensen MS, et al. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2020;5(5):CD012955. doi:10.1002/14651858.CD012955.pub2meta-analise
  20. Cristea IA, Gentili C, Cotet CD, Palomba D, Barbui C, Cuijpers P. Efficacy of psychotherapies for borderline personality disorder: a systematic review and meta-analysis. JAMA Psychiatry. 2017;74(4):319-328. doi:10.1001/jamapsychiatry.2016.4287meta-analise
  21. Linehan MM, Korslund KE, Harned MS, Gallop RJ, Lungu A, Neacsiu AD, et al. Dialectical behavior therapy for high suicide risk in individuals with borderline personality disorder: a randomized clinical trial and component analysis. JAMA Psychiatry. 2015;72(5):475-482. doi:10.1001/jamapsychiatry.2014.3039ensaio
  22. Bateman A, Fonagy P. Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. Am J Psychiatry. 2009;166(12):1355-1364. doi:10.1176/appi.ajp.2009.09040539ensaio
  23. Giesen-Bloo J, van Dyck R, Spinhoven P, van Tilburg W, Dirksen C, van Asselt T, et al. Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy. Arch Gen Psychiatry. 2006;63(6):649-658. doi:10.1001/archpsyc.63.6.649ensaio
  24. McMain SF, Links PS, Gnam WH, Guimond T, Cardish RJ, Korman L, et al. A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. Am J Psychiatry. 2009;166(12):1365-1374. doi:10.1176/appi.ajp.2009.09010039ensaio
  25. Stoffers-Winterling JM, Storebø OJ, Pereira Ribeiro J, Kongerslev MT, Völlm BA, Mattivi JT, et al. Pharmacological interventions for people with borderline personality disorder. Cochrane Database Syst Rev. 2022;11(11):CD012956. doi:10.1002/14651858.CD012956.pub2meta-analise
  26. Stanley B, Brown GK. Safety Planning Intervention: a brief intervention to mitigate suicide risk. Cogn Behav Pract. 2012;19(2):256-264. doi:10.1016/j.cbpra.2011.01.001outro
  27. Hoffman PD, Fruzzetti AE, Buteau E, Neiditch ER, Penney D, Bruce ML, et al. Family Connections: a program for relatives of persons with borderline personality disorder. Fam Process. 2005;44(2):217-225. doi:10.1111/j.1545-5300.2005.00055.xensaio
  28. Chanen A, Sharp C, Hoffman P; Global Alliance for Prevention and Early Intervention for Borderline Personality Disorder. Prevention and early intervention for borderline personality disorder: a novel public health priority. World Psychiatry. 2017;16(2):215-216. doi:10.1002/wps.20429consenso
  29. Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice G. Attainment and stability of sustained symptomatic remission and recovery among patients with borderline personality disorder and axis II comparison subjects: a 16-year prospective follow-up study. Am J Psychiatry. 2012;169(5):476-483. doi:10.1176/appi.ajp.2011.11101550coorte
  30. Gunderson JG, Stout RL, McGlashan TH, Shea MT, Morey LC, Grilo CM, et al. Ten-year course of borderline personality disorder: psychopathology and function from the Collaborative Longitudinal Personality Disorders study. Arch Gen Psychiatry. 2011;68(8):827-837. doi:10.1001/archgenpsychiatry.2011.37coorte

Este material tem caráter educativo e informativo e não substitui a consulta médica. As escalas citadas são instrumentos de triagem e acompanhamento; nenhuma delas fecha diagnóstico sozinha. Diagnóstico e tratamento são sempre definidos pelo médico.